Why Cerevel Therapeutics Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket

Shares of Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) jumped in pre-market trading after AbbVie Inc. (NYSE:ABBV) announced it will acquire the company for a total equity value of approximately $8.7 billion.

AbbVie will acquire all outstanding shares of Cerevel for $45 per share in cash, with the transaction anticipated to close in the middle of 2024.

Cerevel Therapeutics shares rose 14.7% to $42.35 in pre-market trading.

Here are some other stocks moving in pre-market trading.

Gainers

Losers

 

Now Read This: Cramer's Top Auto Pick After 'Very Big Spike': 'By Far The Best Of The Group'

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.